Showing results (111-120 of 302) with videos related to
Sort By:
Pageof 31
BMC Cancer|February 15, 2018
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocolSheeba K Thomas, Soung-Chul Cha, D Lynne Smith, et al.Vaccine|October 16, 2007
Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse modelsKuichun Zhu, Hong Qin, Soung-Chul Cha, et al.Leukemia|September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapyPaolo Strati, Andrew P Jallouk, Ryan Sun, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 27, 2024
Bispecific Antibody Use in Patients With Lymphoma and Multiple MyelomaAdam Braun, Sushanth Gouni, Astrid Pulles, et al.Blood|May 5, 2022
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphomaHua-Jay J Cherng, Ryan Sun, Bryant Sugg, et al.Leukemia & Lymphoma|July 2, 2013
Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemiaPaolo Strati, Alessandra Ferrajoli, Susan Lerner, et al.Cancers|June 22, 2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and BeyondSalvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, et al.Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphomaArnold Freedman, Sattva S Neelapu, Craig Nichols, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In VivoHong Qin, Guowei Wei, Ippei Sakamaki, et al.Pageof 31